
Longeveron Inc.
LGVNHealthcare|Biotechnology|US
$1.81
+0.10 (+5.85%)
Tangible Book / Share
$2.61
Cash / Share
$3.21
Ownership Breakdown
81.8%
Float
3.0M
Shares Outstanding
2.5M
Float Shares
Major Holders (12)
Combined: 80.7%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Mitchell P. Kopin | HC, IN | 9.00% | 2,941,180 | Aug 13, 2026 | 13D/G |
| Intracoastal Capital LLC | Other | 9.00% | 2,941,180 | Aug 13, 2026 | 13D/G |
| Daniel B. Asher | HC, IN | 9.00% | 2,941,180 | Aug 13, 2026 | 13D/G |
| Arsani William | HC, IN | 6.30% | 192,308 | Sep 10, 2026 | 13D/G |
| Graham Walmsley | HC, IN | 6.30% | 192,308 | Sep 10, 2026 | 13D/G |
| Logos Global Management LP | IA, PN | 6.30% | 192,308 | Sep 10, 2026 | 13D/G |
| Logos Global Management GP LLC | HC, OO | 6.30% | 192,308 | Sep 10, 2026 | 13D/G |
| Logos Opportunities Fund V LP | Partnership | 6.30% | 192,308 | Sep 10, 2026 | 13D/G |
| Logos Opportunities V GP LLC | HC, OO | 6.30% | 192,308 | Sep 10, 2026 | 13D/G |
| Janus Henderson Group PLC | Holding company | 5.90% | 1,291,331 | May 15, 2026 | 13D/G |
| Steven Boyd | HC, IN | 4.99% | 676,229 | Nov 14, 2024 | 13D/G |
| Armistice Capital, LLC | IA, OO | 4.99% | 676,229 | Nov 14, 2024 | 13D/G |
Insider Trades (100)
Last 4 quarters: 4,530,000 acquired · 322,138 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jhaveri Nirav S. | Chief Financial Officer | Oct 1, 2026 | TAX W/H | 742 | $2.59 | $1.9K | Form 4 |
| Willard Stephen H | Chief Executive Officer | Oct 1, 2026 | TAX W/H | 1,987 | $2.59 | $5.1K | Form 4 |
| Agafonova Nataliya | Chief Medical Officer | Oct 1, 2026 | TAX W/H | 2,913 | $2.59 | $7.5K | Form 4 |
| Lehr Paul T | General Counsel, Secretary | Oct 1, 2026 | TAX W/H | 2,253 | $2.59 | $5.8K | Form 4 |
| Blass Devin | CTO & SVP of CMC | Oct 1, 2026 | TAX W/H | 2,520 | $2.59 | $6.5K | Form 4 |
| Jhaveri Nirav S. | Chief Financial Officer | Aug 17, 2026 | AWARD | 300,000 | — | — | Form 4 |
| Jhaveri Nirav S. | Chief Financial Officer | Aug 17, 2026 | OTHER | 0 | — | — | Form 4 |
| Lehr Paul T | General Counsel, Secretary | Aug 19, 2026 | AWARD | 286,000 | — | — | Form 4 |
| Hajjar Roger Joseph | director | Aug 19, 2026 | AWARD | 36,000 | — | — | Form 4 |
| Soffer Rock | director | Aug 19, 2026 | AWARD | 36,000 | — | — | Form 4 |
| Paletta George A. Jr. | director | Aug 19, 2026 | AWARD | 36,000 | — | — | Form 4 |
| Ungaro Ursula | director | Aug 19, 2026 | AWARD | 36,000 | — | — | Form 4 |
| Cann Leah Rush | director | Aug 19, 2026 | AWARD | 36,000 | — | — | Form 4 |
| Desai Arjun JJ | director | Aug 19, 2026 | AWARD | 36,000 | — | — | Form 4 |
| Blass Devin | CTO & SVP of CMC | Aug 19, 2026 | AWARD | 286,000 | — | — | Form 4 |
| Agafonova Nataliya | Chief Medical Officer | Aug 19, 2026 | AWARD | 286,000 | — | — | Form 4 |
| Ascheim Deborah | director | Aug 19, 2026 | AWARD | 36,000 | — | — | Form 4 |
| Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | Aug 19, 2026 | AWARD | 286,000 | — | — | Form 4 |
| Washburn Marie | Chief Financial Officer | Jul 13, 2026 | OTHER | 0 | — | — | Form 4 |
| Desai Arjun JJ | director | Jul 2, 2026 | OTHER | 0 | — | — | Form 4 |
| Cann Leah Rush | director | Jul 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Ascheim Deborah | director | Jul 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | Jul 6, 2026 | AWARD | 600,000 | — | — | Form 4 |
| Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | Jul 6, 2026 | AWARD | 400,000 | $0.65 | $260.0K | Form 4 |
| Willard Stephen H | Chief Executive Officer | Jul 1, 2026 | TAX W/H | 18,046 | $0.73 | $13.2K | Form 4 |
| Locklear Lisa | Chief Financial Officer | Jul 1, 2026 | TAX W/H | 22,505 | $0.73 | $16.4K | Form 4 |
| Agafonova Nataliya | Chief Medical Officer | Jul 1, 2026 | TAX W/H | 22,505 | $0.73 | $16.4K | Form 4 |
| Blass Devin | CTO & SVP of CMC | Jul 1, 2026 | TAX W/H | 15,808 | $0.73 | $11.5K | Form 4 |
| Lehr Paul T | General Counsel, Secretary | Jul 1, 2026 | TAX W/H | 13,143 | $0.73 | $9.6K | Form 4 |
| Lehr Paul T | General Counsel, Secretary | May 1, 2026 | AWARD | 250,000 | — | — | Form 4 |
| Willard Stephen H | Chief Executive Officer | May 1, 2026 | AWARD | 500,000 | — | — | Form 4 |
| Blass Devin | CTO & SVP of CMC | May 1, 2026 | AWARD | 250,000 | — | — | Form 4 |
| Agafonova Nataliya | Chief Medical Officer | May 1, 2026 | AWARD | 250,000 | — | — | Form 4 |
| Locklear Lisa | Chief Financial Officer | May 1, 2026 | AWARD | 250,000 | — | — | Form 4 |
| Lehr Paul T | General Counsel, Secretary | Apr 1, 2026 | TAX W/H | 5,611 | $1.12 | $6.3K | Form 4 |
| Agafonova Nataliya | Chief Medical Officer | Apr 1, 2026 | TAX W/H | 13,145 | $1.12 | $14.7K | Form 4 |
| Locklear Lisa | Chief Financial Officer | Apr 1, 2026 | TAX W/H | 13,145 | $1.12 | $14.7K | Form 4 |
| Willard Stephen H | Chief Executive Officer | Apr 1, 2026 | TAX W/H | 4,740 | $1.12 | $5.3K | Form 4 |
| Blass Devin | CTO & SVP of CMC | Apr 1, 2026 | TAX W/H | 8,633 | $1.12 | $9.7K | Form 4 |
| Willard Stephen H | Chief Executive Officer | Mar 2, 2026 | AWARD | 200,000 | — | — | Form 4 |
| Willard Stephen H | Chief Executive Officer | Mar 2, 2026 | AWARD | 200,000 | — | — | Form 4 |
| Willard Stephen H | Chief Executive Officer | Mar 2, 2026 | AWARD | 200,000 | $0.55 | $109.0K | Form 4 |
| Willard Stephen H | Chief Executive Officer | Mar 2, 2026 | TAX W/H | 105,533 | $0.55 | $57.5K | Form 4 |
| Willard Stephen H | Chief Executive Officer | Feb 11, 2026 | OTHER | 0 | — | — | Form 4 |
| Agafonova Nataliya | Chief Medical Officer | Jan 2, 2026 | TAX W/H | 10,250 | $0.59 | $6.1K | Form 4 |
| Lehr Paul T | General Counsel, Secretary | Jan 2, 2026 | TAX W/H | 6,952 | $0.59 | $4.1K | Form 4 |
| Locklear Lisa | Chief Financial Officer | Jan 2, 2026 | TAX W/H | 10,250 | $0.59 | $6.1K | Form 4 |
| Blass Devin | CTO & SVP of CMC | Jan 2, 2026 | TAX W/H | 10,700 | $0.59 | $6.3K | Form 4 |
| Powell James Nathaniel | Chief Executive Officer | Jan 2, 2026 | TAX W/H | 2,464 | $0.59 | $1.5K | Form 4 |
| Paletta George A. Jr. | director | Oct 1, 2025 | AWARD | 34,000 | — | — | Form 4 |
| Paletta George A. Jr. | director | Oct 1, 2025 | OTHER | 0 | — | — | Form 4 |
| Agafonova Nataliya | Chief Medical Officer | Oct 1, 2025 | TAX W/H | 11,883 | $0.74 | $8.8K | Form 4 |
| Powell James Nathaniel | Chief Executive Officer | Oct 1, 2025 | TAX W/H | 2,389 | $0.74 | $1.8K | Form 4 |
| Lehr Paul T | General Counsel, Secretary | Oct 1, 2025 | TAX W/H | 4,944 | $0.74 | $3.7K | Form 4 |
| Blass Devin | CTO & SVP of CMC | Oct 1, 2025 | TAX W/H | 7,609 | $0.74 | $5.6K | Form 4 |
| Locklear Lisa | Chief Financial Officer | Oct 1, 2025 | TAX W/H | 11,883 | $0.74 | $8.8K | Form 4 |
| Powell James Nathaniel | Chief Executive Officer | Sep 4, 2025 | AWARD | 50,000 | — | — | Form 4 |
| Powell James Nathaniel | Chief Executive Officer | Sep 4, 2025 | AWARD | 20,000 | $0.75 | $15.0K | Form 4 |
| Powell James Nathaniel | Chief Executive Officer | Sep 4, 2025 | OTHER | 0 | — | — | Form 4 |
| Powell James Nathaniel | Chief Executive Officer | Aug 11, 2025 | OTHER | 44,115 | $0.85 | $37.5K | Form 4 |
| Locklear Lisa | Chief Financial Officer | Aug 11, 2025 | BUY | 11,766 | — | — | Form 4 |
| Locklear Lisa | Chief Financial Officer | Aug 11, 2025 | BUY | 29,415 | $0.85 | $25.0K | Form 4 |
| Baluch Khoso | director | Aug 11, 2025 | BUY | 11,766 | — | — | Form 4 |
| Baluch Khoso | director | Aug 11, 2025 | BUY | 29,415 | $0.85 | $25.0K | Form 4 |
| Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | Jul 15, 2025 | AWARD | 109,000 | $1.47 | $160.2K | Form 4 |
| Soffer Rock | director | Jul 15, 2025 | AWARD | 17,000 | — | — | Form 4 |
| Agafonova Nataliya | Chief Medical Officer | Jul 15, 2025 | AWARD | 102,000 | — | — | Form 4 |
| Agafonova Nataliya | Chief Medical Officer | Jul 15, 2025 | AWARD | 34,000 | $1.47 | $50.0K | Form 4 |
| Hajjar Roger Joseph | director | Jul 15, 2025 | AWARD | 17,000 | — | — | Form 4 |
| Lehr Paul T | General Counsel, Secretary | Jul 15, 2025 | AWARD | 102,000 | — | — | Form 4 |
| Lehr Paul T | General Counsel, Secretary | Jul 15, 2025 | AWARD | 34,000 | $1.47 | $50.0K | Form 4 |
| Locklear Lisa | Chief Financial Officer | Jul 15, 2025 | AWARD | 102,000 | — | — | Form 4 |
| Locklear Lisa | Chief Financial Officer | Jul 15, 2025 | AWARD | 34,000 | $1.47 | $50.0K | Form 4 |
| Blass Devin | CTO & SVP of CMC | Jul 15, 2025 | AWARD | 102,000 | — | — | Form 4 |
| Blass Devin | CTO & SVP of CMC | Jul 15, 2025 | AWARD | 34,000 | $1.47 | $50.0K | Form 4 |
| Baluch Khoso | director | Jul 15, 2025 | AWARD | 17,000 | — | — | Form 4 |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Jul 15, 2025 | AWARD | 180,000 | — | — | Form 4 |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Jul 15, 2025 | AWARD | 60,000 | $1.47 | $88.2K | Form 4 |
| Kender Richard N | director | Jul 15, 2025 | AWARD | 17,000 | — | — | Form 4 |
| Motwani Neha J. | director | Jul 15, 2025 | AWARD | 17,000 | — | — | Form 4 |
| Ungaro Ursula | director | Jul 15, 2025 | AWARD | 17,000 | — | — | Form 4 |
| Blass Devin | CTO & SVP of CMC | Jul 1, 2025 | TAX W/H | 4,599 | $1.28 | $5.9K | Form 4 |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Jul 1, 2025 | TAX W/H | 13,146 | $1.28 | $16.8K | Form 4 |
| Locklear Lisa | Chief Financial Officer | Jul 1, 2025 | TAX W/H | 7,431 | $1.28 | $9.5K | Form 4 |
| Lehr Paul T | General Counsel, Secretary | Jul 1, 2025 | TAX W/H | 1,562 | $1.28 | $2.0K | Form 4 |
| Agafonova Nataliya | Chief Medical Officer | Jul 1, 2025 | TAX W/H | 7,431 | $1.28 | $9.5K | Form 4 |
| Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | Jul 1, 2025 | AWARD | 49,219 | $1.28 | $63.0K | Form 4 |
| Lehr Paul T | General Counsel, Secretary | Jun 23, 2025 | AWARD | 163,043 | — | — | Form 4 |
| Lehr Paul T | General Counsel, Secretary | Jun 23, 2025 | TAX W/H | 64,158 | $1.15 | $73.8K | Form 4 |
| Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | Jun 13, 2025 | AWARD | 71,254 | $1.33 | $94.8K | Form 4 |
| Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | Jun 13, 2025 | AWARD | 184,878 | $1.49 | $275.5K | Form 4 |
| Soffer Rock | director | May 29, 2025 | SELL | 10,000 | $1.30 | $13.0K | Form 4 |
| Soffer Rock | director | May 30, 2025 | SELL | 11,000 | $1.25 | $13.8K | Form 4 |
| Soffer Rock | director | May 22, 2025 | SELL | 2,000 | $1.32 | $2.6K | Form 4 |
| Hare Joshua | director, 10 percent owner, officer: Chief Scientific Officer | May 16, 2025 | SELL | 5,250 | $1.40 | $7.4K | Form 4 |
| Blass Devin | CTO & SVP of CMC | Apr 16, 2025 | OTHER | 0 | — | — | Form 4 |
| Agafonova Nataliya | Chief Medical Officer | Apr 1, 2025 | TAX W/H | 7,566 | $1.50 | $11.3K | Form 4 |
| Locklear Lisa | Chief Financial Officer | Apr 1, 2025 | TAX W/H | 7,566 | $1.50 | $11.3K | Form 4 |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Apr 1, 2025 | TAX W/H | 13,384 | $1.50 | $20.1K | Form 4 |
| Lehr Paul T | General Counsel, Secretary | Apr 1, 2025 | TAX W/H | 1,599 | $1.50 | $2.4K | Form 4 |